TMO affiliate files Form 144 to sell 7,250 common shares

Rhea-AI Filing Summary

Thermo Fisher Scientific (TMO): Form 144 notice of proposed sale. A holder filed to sell 7,250 shares of common stock, showing an aggregate market value of $4,104,237.84. The approximate sale date is 10/27/2025, with the shares listed on the NYSE. The filing lists 377,612,121 shares outstanding. The broker named is Fidelity Brokerage Services LLC.

The shares to be sold were acquired on 10/27/2025 via an option originally granted on 02/26/2019, with payment stated as cash. The notice also reports recent sales by Marc N. Casper, including 10,000 shares on 08/06/2025 for $4,518,207.00 and 17,104 shares on 10/24/2025 for $9,809,820.07.

Insights

Securities law analyst

Routine Form 144 disclosing a planned affiliate sale.

Form 144 is a notice of a proposed sale of restricted or control securities under Rule 144. This filing lists a plan to sell 7,250 shares of Thermo Fisher Scientific common stock, with an aggregate market value of $4,104,237.84 and an approximate sale date of 10/27/2025. The broker is Fidelity Brokerage Services LLC and the shares trade on the NYSE.

The filing also details how the shares were acquired: via an option granted on 02/26/2019, acquired on 10/27/2025, with cash payment. It lists prior three‑month sales by Marc N. Casper, providing dates, share amounts, and gross proceeds. These disclosures satisfy Rule 144’s transparency requirements.

Impact on the company is typically limited because proceeds go to the selling holder. Actual sale activity depends on market conditions and holder decisions.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	7250	4104237.84	377612121	10/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/27/2025	Option Granted - 02/26/2019	Issuer			7250	10/27/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Marc N. Casper 168 Third Avenue Waltham MA 02451	Common	08/06/2025	10000	4518207.00
Marc N. Casper 168 Third Avenue Waltham MA 02451	Common	08/07/2025	8000	3635549.60
Marc N. Casper 168 Third Avenue Waltham MA 02451	Common	08/19/2025	201	100533.57
Marc N. Casper 168 Third Avenue Waltham MA 02451	Common	08/20/2025	295	147512.36
Marc N. Casper 168 Third Avenue Waltham MA 02451	Common	08/22/2025	10000	5009588.00
Marc N. Casper 168 Third Avenue Waltham MA 02451	Common	09/05/2025	400	200201.00
Marc N. Casper 168 Third Avenue Waltham MA 02451	Common	10/24/2025	17104	9809820.07

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Thermo Fisher Scientific (TMO) disclose in this Form 144?

A notice of intent to sell 7,250 shares of common stock with an aggregate market value of $4,104,237.84, with an approximate sale date of 10/27/2025.

How were the TMO shares to be sold acquired?

They were acquired on 10/27/2025 via an option granted on 02/26/2019, with payment listed as cash.

Which broker and exchange are listed for the proposed TMO sale?

The broker is Fidelity Brokerage Services LLC, and the shares are listed on the NYSE.

How many Thermo Fisher (TMO) shares are listed as outstanding?

The filing lists 377,612,121 shares outstanding.

What recent sales by Marc N. Casper are reported?

Examples include 10,000 shares on 08/06/2025 for $4,518,207.00 and 17,104 shares on 10/24/2025 for $9,809,820.07.

What is the aggregate market value of the proposed 7,250-share sale?

The filing reports an aggregate market value of $4,104,237.84.

Does the Form 144 indicate who receives sale proceeds?

Form 144 concerns sales by the holder; amounts listed for prior sales are reported as gross proceeds.